PHARMACOGENETICS AND DRUG DEVELOPMENT

被引：0
|
作者：
Beaune, P. [1 ]
机构：
[1] INSERM, U775, Paris, France
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [1] Pharmacogenetics and drug development
    Reiser, H
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 417 - 427
  • [2] Pharmacogenetics in drug development
    Becquemont, L.
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (05): : 156 - 160
  • [3] Pharmacogenetics in drug development
    McCarthy, AD
    Kennedy, JL
    Middleton, LT
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1460) : 1579 - 1588
  • [4] Applying pharmacogenetics in drug development
    Roses, AD
    [J]. DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 79 - 80
  • [5] Pharmacogenetics in drug development and pharmacovigilance
    Roses, A. D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 33 - 33
  • [6] Applications of pharmacogenetics in drug therapy and drug development
    Kirchheiner, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 691 - 692
  • [7] Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development
    Akkari, P. Anthony
    Swanson, Thomas W.
    Crenshaw, Donna G.
    Grossman, Iris
    Sundseth, Scott
    Burns, Daniel K.
    Roses, Allen D.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (32) : 3754 - 3763
  • [8] Challenges and opportunities of pharmacogenetics in drug development
    March, Ruth
    [J]. PERSONALIZED MEDICINE, 2006, 3 (02) : 195 - 206
  • [9] Pharmacogenetics and future drug development and delivery
    Roses, AD
    [J]. LANCET, 2000, 355 (9212): : 1358 - 1361
  • [10] Pharmacogenetics in drug development: Regulatory and clinical considerations
    Hall, ST
    Abbott, N
    Schmith, G
    Brazell, C
    [J]. DRUG DEVELOPMENT RESEARCH, 2004, 62 (02) : 102 - 111
12345